Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Bast

Showing results (81-90 of 106) with videos related to

Pageof 11
Sort By:
Orphanet Journal of Rare Diseases|April 29, 2023
Sleep quality, anxiety, symptoms of depression, and caregiver burden among those caring for patients with Dravet syndrome: a prospective multicenter study in GermanyMargarita Maltseva, Susanne Schubert-Bast, Johann Philipp Zöllner, et al.
European Journal of Paediatric Neurology : EJPN : Official Journal of the European Paediatric Neurology Society|March 16, 2019
Burden-of-illness and cost-driving factors in Dravet syndrome patients and carers: A prospective, multicenter study from GermanyAdam Strzelczyk, Malin Kalski, Thomas Bast, et al.
Epilepsy & Behavior : E&B|July 14, 2019
Seizure management and prescription patterns of anticonvulsants in Dravet syndrome: A multicenter cohort study from Germany and review of literatureSusanne Schubert-Bast, Markus Wolff, Adelheid Wiemer-Kruel, et al.
Epilepsia|June 28, 2019
A multicenter, matched case-control analysis comparing burden-of-illness in Dravet syndrome to refractory epilepsy and seizure remission in patients and caregivers in GermanyAdam Strzelczyk, Susanne Schubert-Bast, Thomas Bast, et al.
Science Translational Medicine|September 13, 2021
4-Aminopyridine is a promising treatment option for patients with gain-of-function <i>KCNA2</i>-encephalopathyUlrike B S Hedrich, Stephan Lauxmann, Markus Wolff, et al.
Annals of Neurology|April 23, 2015
Intelligence quotient improves after antiepileptic drug withdrawal following pediatric epilepsy surgeryKim Boshuisen, Monique M J van Schooneveld, Cuno S P M Uiterwaal, et al.
Human Mutation|October 23, 2012
Kohlschütter-Tönz syndrome: mutations in ROGDI and evidence of genetic heterogeneityArianna Tucci, Eleanna Kara, Anna Schossig, et al.
Annals of Neurology|December 18, 2015
Benign infantile seizures and paroxysmal dyskinesia caused by an SCN8A mutationElena Gardella, Felicitas Becker, Rikke S Møller, et al.
Seizure|January 29, 2016
Effectiveness of antiepileptic therapy in patients with PCDH19 mutationsJan Lotte, Thomas Bast, Peter Borusiak, et al.
Expert Review of Clinical Pharmacology|April 1, 2021
Prescription patterns of antiseizure drugs in tuberous sclerosis complex (TSC)-associated epilepsy: a multicenter cohort study from Germany and review of the literatureAdam Strzelczyk, Janina Grau, Thomas Bast, et al.
Pageof 11

Showing results (81-90 of 106) with videos related to

Sort By:
Pageof 11
Orphanet Journal of Rare Diseases|April 29, 2023
Sleep quality, anxiety, symptoms of depression, and caregiver burden among those caring for patients with Dravet syndrome: a prospective multicenter study in GermanyMargarita Maltseva, Susanne Schubert-Bast, Johann Philipp Zöllner, et al.
European Journal of Paediatric Neurology : EJPN : Official Journal of the European Paediatric Neurology Society|March 16, 2019
Burden-of-illness and cost-driving factors in Dravet syndrome patients and carers: A prospective, multicenter study from GermanyAdam Strzelczyk, Malin Kalski, Thomas Bast, et al.
Epilepsy & Behavior : E&B|July 14, 2019
Seizure management and prescription patterns of anticonvulsants in Dravet syndrome: A multicenter cohort study from Germany and review of literatureSusanne Schubert-Bast, Markus Wolff, Adelheid Wiemer-Kruel, et al.
Epilepsia|June 28, 2019
A multicenter, matched case-control analysis comparing burden-of-illness in Dravet syndrome to refractory epilepsy and seizure remission in patients and caregivers in GermanyAdam Strzelczyk, Susanne Schubert-Bast, Thomas Bast, et al.
Science Translational Medicine|September 13, 2021
4-Aminopyridine is a promising treatment option for patients with gain-of-function <i>KCNA2</i>-encephalopathyUlrike B S Hedrich, Stephan Lauxmann, Markus Wolff, et al.
Annals of Neurology|April 23, 2015
Intelligence quotient improves after antiepileptic drug withdrawal following pediatric epilepsy surgeryKim Boshuisen, Monique M J van Schooneveld, Cuno S P M Uiterwaal, et al.
Human Mutation|October 23, 2012
Kohlschütter-Tönz syndrome: mutations in ROGDI and evidence of genetic heterogeneityArianna Tucci, Eleanna Kara, Anna Schossig, et al.
Annals of Neurology|December 18, 2015
Benign infantile seizures and paroxysmal dyskinesia caused by an SCN8A mutationElena Gardella, Felicitas Becker, Rikke S Møller, et al.
Seizure|January 29, 2016
Effectiveness of antiepileptic therapy in patients with PCDH19 mutationsJan Lotte, Thomas Bast, Peter Borusiak, et al.
Expert Review of Clinical Pharmacology|April 1, 2021
Prescription patterns of antiseizure drugs in tuberous sclerosis complex (TSC)-associated epilepsy: a multicenter cohort study from Germany and review of the literatureAdam Strzelczyk, Janina Grau, Thomas Bast, et al.
Pageof 11